In summary, there may be two major mechanisms by which Fbx2 regulates synaptic plasticity in AD mouse models: one is through a direct regulation of synaptic neurotransmitter release and receptor turnover; the second may be due to stimulation of the degradation of BACE1/APP to reduce Aβ levels in the brain. Here, BACE1 is linked to Alzheimer disease.